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Background: Verbal autopsy (VA) is the only available approach for determining the cause of many deaths,
where routine certification is not in place. Therefore, it is important to use standards and methods for VA that
maximise efficiency, consistency and comparability. The World Health Organization (WHO) has led the deve-
lopment of the 2012 WHO VA instrument as a new standard, intended both as a research tool and for routine
registration of deaths.
Objective: A new public-domain probabilistic model for interpreting VA data, InterVA-4, is described, which
builds on previous versions and is aligned with the 2012 WHO VA instrument.
Design: The new model has been designed to use the VA input indicators defined in the 2012 WHO VA
instrument and to deliver causes of death compatible with the International Classification of Diseases version
10 (ICD-10) categorised into 62 groups as defined in the 2012 WHO VA instrument. In addition, known
shortcomings of previous InterVA models have been addressed in this revision, as well as integrating other
work on maternal and perinatal deaths.
Results: The InterVA-4 model is presented here to facilitate its widespread use and to enable further field
evaluation to take place. Results from a demonstration dataset from Agincourt, South Africa, show continuity
of interpretation between InterVA-3 and InterVA-4, as well as differences reflecting specific issues addressed in
the design and development of InterVA-4.
Conclusions: InterVA-4 is made freely available as a new standard model for interpreting VA data into causes
of death. It can be used for determining cause of death both in research settings and for routine registration.
Further validation opportunities will be explored. These developments in cause of death registration are likely
to substantially increase the global coverage of cause-specific mortality data.
Keywords: verbal autopsy; cause of death; vital registration; InterVA; World Health Organization
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V
erbal autopsy (VA) covers the entire process
of interviewing close caregivers  relatives, friends
or witnesses  about the details of a death that
occurred and then uses the interview data to arrive at a
probable cause of death. This is not a new concept, and
although VA might not necessarily be the best or most
accurate approach for determining individual causes of
death, it is nevertheless a much better option than simply
allowing deaths to pass unrecorded. Provided VA is
implemented with reasonable rigour and consistency, it
leads to information on cause-specific mortality patterns
which are otherwise unavailable. The need for more
comprehensive death registration, and the potential con-
tribution of VA in this, is described in a recent blog (1).
In recent years increasing attention has been paid
to computerised procedures for determining cause of
death from VA data (2). VA data have commonly been
interpreted by physicians, but this has proved to be
a costly, slow and non-reproducible process in many
situations, yielding VA cause of death information that
cannot readily be compared between settings (3). Pro-
ponents of physician interpretation argue that a more
nuanced approach to detailed causes of death (including
co-morbidities) can be achieved by physicians consider-
ing a narrative account of the circumstances leading to
death (4), while computerised processes can be compara-
tively fast, cheap and reproducible over time and place,
and also speed up VA interviews by obviating the need
for transcribing lengthy narratives (5).
Over the past decade, a series of InterVA models have
been developed using Bayesian probabilistic modelling
as a means of interpreting VA data to derive causes of
death. Starting on a very experimental basis with VA data
from Vietnam (6), these models progressed to InterVA-3
which has been widely used in a variety of settings across
Africa, Asia and Latin America (715) and an associated
model, InterVA-M, which dealt separately with deaths
among women of reproductive age (16, 17). Additional
developments for handling neonatal deaths have also
been reported previously (18).
In parallel with these technical developments for
ascertaining cause of death, concern has grown about
the large proportion of deaths in the world that are not
certified by cause and which therefore contribute nothing
to global evidence on cause of death and the implications
for public health. It is also clear that the chances of a
death being registered are strongly determined by geo-
graphic location and socio-economic status (19), meaning
that widening the scope of death registration (including
cause determination) also represents a means of reducing
global bias in cause of death information. This has led the
World Health Organization (WHO), the Health Metrics
Network and the United Nations Statistical Commission
to seek ways forward for extending routine death registra-
tion on a much wider scale. Hitherto VA has been largely
used in research settings, such as the Health and Demo-
graphic Surveillance Sites of the INDEPTH Network
(20). Now, particularly with the development of shorter
and more automated methods, VA offers new opportu-
nities for wider implementations of routine cause of
death registration, not only in research environments.
This paper presents the underlying principles of the
latest model in the InterVA suite, InterVA-4, which inte-
grates experience accumulated from previous versions,
latest data and research findings, and revisions by an
expert panel. The InterVA-4 model is freely available and
can be downloaded from www.interva.net. The InterVA-4
User Guide is attached to this paper as Supplementary
Material. As well as reflecting previous experience, this
latest model has been constructed to reflect the structure
of the 2012 WHO Verbal Autopsy instrument, developed
in an expert consultation in Geneva in December 2011
(21). InterVA-4 aims to provide a consistent and generally
applicable means of interpreting VA data, being modelled
on (but not restricted to) the 2012 WHO Verbal Autopsy
instrument, and hence applicable prospectively and retro-
spectively. The model is intended for use both within
already-enumerated populations and as a stand-alone
death registration tool, both in research and in civil
registration.
Probabilistic methods
Bayes’ theorem (22) links the probability of an event
happening given a particular circumstance with the
unconditional probability of the same event and the con-
ditional probability of the circumstance given the event.
If the event of interest is a particular cause of death,
and the circumstance is part of the events leading to
death, then Bayes’ theorem can be applied in terms of
circumstances and causes of death.
Specifically, if there are a predetermined set of possible
causes of death C1 . . . Cm and another set of indicators
I1 . . . In representing various signs, symptoms and cir-
cumstances leading to death, then Bayes’ general theorem
for any particular Ci and Ij can be stated as:
P(Ci½Ij)
P(Ij½Ci) P(Ci)
P(Ij½Ci) P(Ci) P(Ij½!Ci) P(!Ci)
where P(!Ci) is (1P(Ci)).
Over the whole set of causes of death C1 . . . Cm a set
of probabilities for each Ci can be calculated using
a normalising assumption so that the total conditional
probability over all causes totals unity:
P(Ci½Ij)
P(Ij½Ci) P(Ci)
Pm
i1 P(Ci)
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Using an initial set of unconditional probabilities for
causes of death C1 . . . Cm (which can be thought of as
P(CijI0)) and a matrix of conditional probabilities P(IjjCi)
for indicators I1 . . . In and causes C1 . . . Cm, it is possible
to repeatedly apply the same calculation process for each
I1 . . . In that applies to a particular death:
P(Ci½I1 ... n)
P(Ij½Ci) P(Ci½I0 ... n1)
Pm
i1 P(Ci½I0 ... n1)
This process typically results in the probabilities of
most causes reducing, while a few likely causes are char-
acterised by their increasing probabilities as successive
indicators are processed.
The InterVA-4 model
InterVA-4 aims to be a tool for interpreting VA data which
can be applied simply, quickly and cheaply to generate
cause of death data, compatible with the International
Classification of Diseases version 10 (ICD-10). It offers
the consistency and reproducibility that is characteristic
of mathematical models and thus facilitates comparisons
of VA cause of death between different places and over
time. Furthermore, as a public-domain resource it is freely
available and runs on any Windows†-based personal
computer, or under the Mac OS† as a virtual Windows†
instance. It builds on experience with previous InterVA
models but brings a new standard of VA interpretation by
conforming to the 2012 WHO VA instrument in terms of
cause of death categories and input indicators. Indicators
relating to durations in the WHO instrument are split into
pre-defined categories for processing in InterVA-4. Tables
of cause of death categories and input indicators from the
2012 WHO VA instrument as handled by InterVA-4 are
included in the InterVA-4 User Guide (Supplementary
Material).
For deaths among women of reproductive age, a
separate sub-model is incorporated which uses exactly
the same methodology over three pregnancy status out-
comes to assess the likelihood of pregnancy being as-
sociated with the death (but not necessarily in a causal
sense). This was previously implemented in InterVA-M
and is important in cases where pregnancy status at death
may be ambiguous in the VA data (16).
Apart from the mathematics, the major challenge in
building a probabilistic model covering all causes of
death to a reasonable level of detail lies in populating
the matrix of conditional probabilities P(IjjCi). There is
no overall source of data available which systematically
quantifies probabilities of various signs, symptoms and
circumstances leading to death in terms of their associa-
tions with particular causes. Therefore, these conditional
probabilities have to be estimated from a diversity of
incomplete sources (including previous InterVA models)
and modulated by expert opinion. In the various versions
of InterVA that have been developed, expert panels have
been convened to capture clinical expertise on the rela-
tionships between indicators and causes (23). In this case,
an expert panel (DC, AH, SH, AK, KK) convened in
Geneva in December 2011 and continued to deliberate
subsequently, particularly considering issues that built
on previous InterVA versions. Experience has shown that
gradations in levels of perceived probabilities correspond
more to a logarithmic than linear scale (24), and in the
expert consultation for InterVA-4, we used a perceived
probability scale that was subsequently converted to
numbers on a logarithmic scale as shown in Table 1. This
was similar to scales used previously but was extended
into additional low probability categories. We have also
demonstrated by means of sensitivity analyses within the
probability matrix that although the conditional prob-
ability values are important, the model does not require
a high level of precision for these estimates (25).
As was the case in InterVA-3 (5), there are special
arrangements for two causes of death (HIV/AIDS and
malaria), the occurrences of which vary appreciably in
different locations. As described in the InterVA-4 User
Guide, the model has a facility for setting the uncondi-
tional probabilities for each of these causes to reflect their
occurrence in a particular population. Conceptually, this
is analogous to a physician’s background knowledge
of local disease profiles, irrespective of the details of
a particular case. In the new model, the setting for
malaria is also applied to the unconditional probability
for deaths due to sickle cell disease, because of the
genetically determined geographical overlap between the
two diseases (26).
Having experienced difficulties in previous versions of
the software with proprietary data file formats, which tend
to change in unpredictable ways over time, InterVA-4
Table 1. Qualitative probability scale used as the basis for
eliciting expert opinion on probabilities
Label Value Interpretation
I 1.0 Always
A 0.8 Almost always
A 0.5 Common
A 0.2
B 0.1 Often
B 0.05
B 0.02
C 0.01 Unusual
C 0.005
C 0.002
D 0.001 Rare
D 0.0005
D 0.0001
E 0.00001 Hardly ever
N 0 Never
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has reverted to text with comma-separated values (CSVs)
for data input and output, as the lowest common
denominator in file formats. CSV data can be relatively
easily read and written by most analysis software pack-
ages, and examples of Stata scripts for generating
InterVA-4 input and processing output from InterVA-4
in a standard way, deriving cause-specific mortality
fractions (CSMFs), are included in the user guide.
Having calculated a set of conditional probabilities
P(CijI1 . . . n) for causes C1 . . . Cm for each case, methods
have to be applied for interpreting the output in ways that
make sense from medical cause of death and public health
perspectives. In the interests of transparency, InterVA-4
automatically outputs the complete P(CijI1 . . . n) data grid
for all causes and cases in a batch as a CSV file. However,
this is not a very convenient format for routinely analysing
cause of death data; hence, the InterVA-4 software also
undertakes basic post-processing of the basic cause of
death data into a more readily useable format. Although
experience shows that the majority of cases arrive at a
single overwhelmingly likely cause, some cases, particu-
larly if there is scanty or somewhat contradictory infor-
mation available, may end up with two or three causes
of comparable likelihood. This is analogous to a physi-
cian’s differential diagnosis in which ambiguity remains
between multiple likely causes. In a further minority of
cases, there is no high likelihood cause, amounting to no
clear conclusion on cause of death. To handle all this in a
standardised way, InterVA-4 post-processes likely cause
data in the same way that we have previously discussed in
relation to InterVA-3 (5). If no single cause has a final
likelihood of at least 0.4, the cause of death is considered
to be indeterminate. The 0.4 cut-off is considerably higher
than the unconditional probability of any cause, and con-
ceptually includes a level approaching a 50:50 possibility
for a particular cause, while leaving scope for other likely
causes to be included in the overall consideration of the
case. Multiple causes are only reported if they reach half
of the likelihood of the leading cause. Any residual margin
of likelihood not accounted for by the likelihood of the
first and, where applicable, second and third causes can
then be considered as a partial indeterminate component
in analysing overall cause of death and CSMF patterns.
We suggest that this is a much more appropriate approach
than aggregating the sums of small residual probabilities
of unlikely causes, which can lead to misleading results
over large numbers of cases.
Since an important part of the objectives behind this
model is to extend the use of VA into routine death
registration procedures, additional non-medical questions
about circumstances of death have been included in the
2012 WHO VA instrument to facilitate the interpreta-
tion of cause of death in non-enumerated populations.
Although these are not in any way intended to replace
the developing role of social autopsy (27), future devel-
opments in describing and modelling non-medical factors
associated with cause of death are anticipated and will
be reflected in future developments of InterVA.
Comparing InterVA-3 and InterVA-4
As with any software tool, one of our aims in developing
this new version of InterVA was to improve the scope
of the tool and address known shortcomings of the
previous version. The differences between InterVA-3 and
InterVA-4 are considerable, even though the same basic
mathematical model lies at the heart of both versions.
Both the range of causes of death and the scope of in-
put indicators are considerably expanded in the new
version and brought into line with the 2012 WHO VA
instrument, but this makes a direct and meaningful
comparison between the versions difficult. To demon-
strate the similarities and differences, we have taken
a random sample of 1,000 cases from the Agincourt,
South Africa, dataset previously analysed (5). These cases
have been run with the InterVA-3 and InterVA-4 models,
but without adding data for the additional InterVA-4
indicators. Age-specific CSMFs from both models for
these same 1,000 cases are shown in Table 2. This de-
monstrates the more detailed classification of neoplasms
in the new model, as well as the detailed maternal causes
brought in from InterVA-M. This illustrative dataset
included 44/62 of the 2012 WHO VA instrument possible
causes of death.
Discussion
The new InterVA-4 model presented here represents
a substantial advance in automated cause of death
modelling. It is specifically aligned to the new WHO
2012 Verbal Autopsy instrument (21), although it can be
used retrospectively for processing archived VA data,
provided a reasonable spread of the necessary indicators
are available. It offers the advantages of standardised
interpretation over time and place; is freely available as a
public-domain resource; and on a typical computer can
process around 10,000 cases per hour. These attributes
mean that it offers new opportunities for cause of death
data to be gathered routinely in settings where hitherto
there have been few or no such records and where
physicians to assess VAs are few. The speed of processing
can yield cause of death information with the potential
to feed into local and national health policy development
in a timely fashion. Standardised assessment means that
trends in causes of death can be tracked over time and
can be compared across different settings. We have
previously shown that using a standard model across a
wide range of settings yields appreciably different, and
plausible, cause of death profiles (28).
The potential disadvantage of using any mathematical
model for interpreting cause of death is that some
subtlety and nuance may be lost as compared to routine
Peter Byass et al.
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Table 2. Comparison of age- and cause-specific mortality fractions (CSMF) using the InterVA-3 and InterVA-4 models on 1,000 randomly selected VA records from a previous
analysis of data in Agincourt HDSS, South Africa (12)
Cause-specific mortality fractions by age group (%)
All-age 5 28 days 111 months 14 years 514 years 1549 years 5064 years 65 years
n1000 n15 n50 n79 n35 n437 n139 n245
InterVA-4 cause (WHO 2012 categories*) v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 InterVA-3 cause
01.02 ARI, including pneumonia 5 4 35 25 11 6 3 1 1 5 5 4 6 Pneumonia/sepsis
01.03 HIV/AIDS related death 19 17 16 22 39 49 15 6 25 25 16 8 4 0 HIV/AIDS-related death
01.04 diarrhoeal diseases 3 2 10 21 13 5 4 3 0 2 1 1 Diarrhoea
01.05 malaria 1 0 5 4 4 1 0 2 0 Malaria
01.07 meningitis 0 2 2 5 1 3 15 1 1 2 Meningitis
01.08 tetanus 0 0 1 Tetanus
01.09 pulmonary tuberculosis 19 20 1 5 4 10 5 25 26 21 20 19 22 Pulmonary tuberculosis
01.10 pertussis 0 2 0
01.99 other infectious diseases 3 2 8 3 4 4
02.01 oral neoplasms 0 1 0 2 0 3 Malignancy
02.02 digestive neoplasms 4 2 9 8
02.03 respiratory neoplasms 3 2 4 5
02.05, 02.06 reproductive neoplasms 2 1 0 5
02.99 other neoplasms 1 1 0 2
03.02 severe malnutrition 0 0 3 0 0 1 Malnutrition
03.03 diabetes mellitus 2 3 2 1 5 1 1 2 4 5 5 Diabetes
04.01 acute cardiac disease 1 0 1 0 1 1 2 0 Acute cardiac death
04.02 stroke 1 1 0 2 1 1 2 Stroke
04.03 sickle cell with crisis 1 1 11 0 Haemoglobinopathy
04.99 other cardiac disease 2 4 3 4 1 2 2 8 4 9 Chronic cardiac death
05.01 COPD 1 2 0 1 1 5 3 3 Chronic respiratory disease
05.02 asthma 1 3 1 1
06.01 acute abdomen 2 1 2 2 2 4
06.02 liver cirrhosis 0 4 1 0 2 1 6 1 8 Liver disease
07.01 renal failure 1 1 2 1 0 2 2 1 4 Kidney disease
08.01 epilepsy 1 0 1 4 1 0 1 Disease of nervous system
98 other NCD 0 0 0 0 0
09.01 ectopic pregnancy 0 0 0 1 Maternal-related death
09.02 abortion-related death 0 0
09.06 pregnancy-related sepsis 0 0
09.07 anaemia of pregnancy 0 0
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Table 2 (Continued)
Cause-specific mortality fractions by age group (%)
All-age 5 28 days 111 months 14 years 514 years 1549 years 5064 years 65 years
n1000 n15 n50 n79 n35 n437 n139 n245
InterVA-4 cause (WHO 2012 categories*) v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 v4 v3 InterVA-3 cause
10.01 prematurity 0 0 24 13 2 Pre-term/small baby
10.02 birth asphyxia 0 1 19 43 Perinatal asphyxia
10.03 neonatal pneumonia 1 0 40 26 Pneumonia/sepsis
10.06 congenital malformation 0 4
10.99 other neonatal conditions 0 5
12.01 road traffic accident 3 4 0 1 4 6 10 5 6 2 2 1 1 Transport-related accident
12.03 accidental fall 0 1 3
12.04 accidental drowning 0 0 1 1 6 5 Accidental drowning
12.05 smoke, fire and flames 0 1 1
12.07 accidental poisoning 1 1 1 3 0 1 1 0 Accidental poisoning
12.08 intentional self-harm 1 1 3 3 2 1 1 1 1 Suicide
12.09 assault 4 3 2 7 6 4 4 0 0 Homicide
12.99 other external causes 1 0 1 3 1 4 1 1 0 2 2 0 Other fatal accident
99 indeterminate 17 29 12 18 18 23 11 22 23 36 12 26 15 31 19 31 Indeterminate
Total over all causes 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
*These demonstration data included 44/62 of the cause of death categories in the 2012 WHO VA instrument and InterVA-4.
CSMFs are rounded to nearest 1%, 0 representing a finite valueB0.5%.
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physician certification of cause of death (either from
attending physicians or from physicians coding individual
VA cases). It is certainly true that mathematical models
will fail to identify very unusual or complex causes of
death. However, such cases tend to be of more local or
esoteric interest rather than contributing significantly to
the public health understanding of population mortality
patterns.
Considering the validity of any VA approach raises
difficult issues. VA is normally used in settings where
other sources of information on circumstances of death
are lacking, precluding many direct comparisons. The VA
interview stage carries inherent uncertainty as the quality
of information obtained depends on a variety of factors
including relationship of respondent to deceased, knowl-
edge of signs and symptoms during terminal illness, recall
and willingness to disclose information, especially for
conditions that are stigmatised or have culturally sensitive
connotations (29). The absolute validity of deaths certi-
fied by attending physicians is by no means a given, and
studies have shown considerable inconsistencies between
hospital causes of death and pathologists’ findings (30, 31).
The validity of physician interpretation of VA material
has also been shown to be questionable (3) and subject
to inter-observer variation (12). It is also clear that any
approach to VA data must involve some degree of
capturing expert opinion, alongside the use of established
information (32). Previous InterVA models have been
extensively evaluated against local physician interpre-
tations, with generally concordant findings (5, 7, 10, 12,
14, 15). One evaluation suggested that InterVA-3 did not
perform well against VA data from tertiary health facilities
(33), but those data were not available for further study.
Nevertheless, certain shortcomings have been identified in
InterVA-3, including over-diagnosis of meningitis, under-
diagnosis and lack of differentiation between various
cancers, and fairly high levels of indeterminate cases.
InterVA-4 is designed to handle these more effectively,
and we will continue to explore realistic opportunities for
further validations.
The comparison between InterVA-3 and InterVA-4
demonstrated in Table 2 says nothing about the absolute
validity of either model or about the mortality profile in
the Agincourt population. It does demonstrate, however,
the general continuity in results between the two versions
of the model, when using exactly the same input data,
as well as evidence of deliberately introduced changes
in response to some of the shortcomings identified in
InterVA-3. This comparison does not necessarily make
the most of some of the new aspects of InterVA-4, since
data for new indicators were not included in order
to demonstrate continuity. We will continue to make
InterVA-3 and InterVA-M available as legacy downloads,
but we recommend the use of InterVA-4 wherever
possible.
InterVA-4 is launched here as a global resource. It
offers substantial benefits over the default situation of
not routinely capturing cause of death data (which is
the de facto standard in many resource-limited parts
of the world), considerable improvements over previous
versions and the ability to more reliably compare causes
of death across different settings and over time. This is
important for research, for example, as INDEPTH cross-
site research accelerates (20), and also offers new oppor-
tunities for cause-specific civil registration of deaths on
a much wider scale. Work is in progress on a portable
electronic version of the model which will be particularly
useful for routine registration. In the longer term, there
will undoubtedly be further evaluations and develop-
ments as the science and methods of attributing cause
of death improve. We will continue to work with old and
new collaborators on further refinements in this process.
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